TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024

Code : CMI4936

Pages :167

Formats :

Excel and PDF

Industry : Pharmaceutical

Key Takeaways from Analyst

The global TCV vaccines market is expected to witness steady growth over the forecast period owing to rising prevalence of infectious tropical diseases like typhoid and cholera. Increasing awareness about vaccination programs across emerging nations will drive further the demand for these vaccines.

The Asia Pacific region dominates the global TCV vaccines industry currently due to high burden of typhoid and cholera infections. The Africa is projected to be the fastest-growing region for the TCV vaccines market due to various factors, including increased disease prevalence, government immunization efforts, and global health initiatives aimed at controlling typhoid fever.

Availability of novel vaccines with added advantages over traditional TCV vaccines will open lucrative growth avenues for leading players. However, lengthy regulatory approvals for new vaccines will remain a challenge.